The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.
Yueer Shi
Advertisement
Yueer Shi is group leader, Bristol Myers Squibb, USA, yueer.shi@bms.com
Articles by Yueer Shi
Advertisement
Latest Updated Articles
Covalidation Strategies to Accelerate Analytical Method Transfer for Breakthrough TherapiesPublished: April 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
FDA Deploys Agentic AI Capabilities for Agency Staff
4
Live Cell High-Content Imaging is Driving Drug Discovery
5
